VULVAR, VAGINAL, PENILE, RECTAL CANCER
Clinical trials for VULVAR, VAGINAL, PENILE, RECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new VULVAR, VAGINAL, PENILE, RECTAL CANCER trials appear
Sign up with your email to follow new studies for VULVAR, VAGINAL, PENILE, RECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise against Hard-to-Treat HPV cancers
Disease control OngoingThis study tests whether a mix of three immunotherapy drugs can shrink tumors in people with advanced HPV-related cancers that have spread or not responded to standard treatments. About 51 adults with cancers like cervical, anal, or throat cancer will receive the drugs for up to …
Matched conditions: VULVAR, VAGINAL, PENILE, RECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New HPV vaccine combo shows promise against tough cancers
Disease control OngoingThis study tests an HPV vaccine (PRGN-2009) alone or combined with a drug called M7824 in adults with HPV-positive cancers like cervical, anal, and throat cancers. The goal is to find a safe dose and see if the combination boosts the immune system's attack on tumors. Participants…
Matched conditions: VULVAR, VAGINAL, PENILE, RECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:37 UTC